Table 2 — Immune Modulators With No Completed Studies In Type 2 Diabetic Patients1
|
• Azathioprine Continue Reading • Cyclosporine • Cyclophosphamide • Leflunomide • Minocycline • Mycophenolate mofetil • Abatacept • Alefacept • Rituximab • Tocilizumab |
Please login or register first to view this content.
You’ve read {{metering-count}} of {{metering-total}} articles this month.
We want you to take advantage of everything MPR has to offer. To view unlimited content, log in or register for free.
{{login-button}} {{register-button}}
Want to view more content from MPR?
Register now at no charge to access unlimited daily drug news, medication safety alerts & recalls, and industry-supported drug information & education.
{{login-button}} {{register-button}}
Please login or register first to view this content.
